BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
Methods: Four hundred and sixty-one adult subjects with migraine were randomised to one of five treatments, the oral antagonist at the calcitonin gene-related peptide (CGRP) receptor BI 44370 TA (50 mg, 200 mg, 400 mg), active comparator eletriptan 40 mg or placebo. The analysis included 341 subject...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | 英语 |
| 出版: |
2010
|
| 在线阅读: | https://doi.org/10.1177/0333102410388435 https://journals.sagepub.com/doi/pdf/10.1177/0333102410388435 |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|